LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial by Christian Loesche, Damien Picard, Benjamin Van Hoorick, Imelda Schuhmann, Petra Jäger, Kai Klein, Carole Schuhler, Gebhard Thoma, Christian Markert, Birk Poller, Natasa Zamurovic, H. Markus Weiss, Heike Otto, Martin Fink, Till A. Röhn

Get full text